US5288497A
(en)
*
|
1985-05-01 |
1994-02-22 |
The University Of Utah |
Compositions of oral dissolvable medicaments
|
US5824334A
(en)
*
|
1989-09-05 |
1998-10-20 |
University Of Utah Research Foundation |
Tobacco substitute
|
IT1238072B
(en)
*
|
1990-01-19 |
1993-07-03 |
Sclavo Spa |
PHARMACEUTICAL COMPOSITIONS AND DOSAGE FORMS FOR ORAL ADMINISTRATION OF CALCITONIN
|
US5223259A
(en)
*
|
1990-09-19 |
1993-06-29 |
Lackney Albert M |
Securing means for an oral medicament and support therefor
|
WO1993010758A1
(en)
*
|
1991-12-05 |
1993-06-10 |
Pitman-Moore, Inc. |
A carbohydrate glass matrix for the sustained release of a therapeutic agent
|
WO1993012769A1
(en)
*
|
1991-12-24 |
1993-07-08 |
Yamanouchi Pharmaceutical Co., Ltd. |
Intrabuccally disintegrating preparation and production thereof
|
GB9212511D0
(en)
*
|
1992-06-12 |
1992-07-22 |
Cortecs Ltd |
Pharmaceutical compositions
|
GB9213874D0
(en)
*
|
1992-06-30 |
1992-08-12 |
Fisons Plc |
Process to novel medicament form
|
JPH0776527A
(en)
*
|
1993-06-28 |
1995-03-20 |
Hayashibara Biochem Lab Inc |
Semi-solid preparation and production thereof
|
US5549906A
(en)
*
|
1993-07-26 |
1996-08-27 |
Pharmacia Ab |
Nicotine lozenge and therapeutic method for smoking cessation
|
WO1995003771A1
(en)
*
|
1993-08-03 |
1995-02-09 |
Pacific Rim Productions Pty. Ltd. |
Treatment of oral ailments
|
US6352713B1
(en)
|
1999-12-01 |
2002-03-05 |
Drugtech Corporation |
Nutritional composition
|
US6488956B1
(en)
*
|
1994-06-20 |
2002-12-03 |
Drugtech Corporation |
Multi-vitamin and mineral supplements for women
|
MA23587A1
(en)
*
|
1994-06-23 |
1995-12-31 |
Procter & Gamble |
TREATMENT OF NEED FOR NICOTINE AND / OR SMOKING-RELATED SYNDROME
|
WO1996000069A1
(en)
*
|
1994-06-23 |
1996-01-04 |
The Procter & Gamble Company |
Treatment of nicotine craving and/or smoking withdrawal symptoms with a solid or semi-solid composition containing nicotine and caffeine or xanthine, especially for nasal administration
|
WO1996000072A1
(en)
*
|
1994-06-23 |
1996-01-04 |
The Procter & Gamble Company |
Treatment of nicotine craving and/or smoking withdrawal symptoms with a transdermal or transmucosal composition containing nicotine and caffeine or xanthine
|
GB2325408B
(en)
*
|
1994-06-28 |
1999-01-27 |
Kenneth Francis Prendergast |
Chewing gum formulation comprising ondansetron
|
GB9423511D0
(en)
*
|
1994-11-22 |
1995-01-11 |
Glaxo Wellcome Inc |
Compositions
|
CN1172433A
(en)
*
|
1995-02-02 |
1998-02-04 |
中外制药株式会社 |
Sucralfate preparation
|
US5788982A
(en)
*
|
1995-06-16 |
1998-08-04 |
Nadoolman; Wolffe |
Method and composition for treating oral pain using capsaicin
|
GB9517062D0
(en)
*
|
1995-08-18 |
1995-10-25 |
Scherer Ltd R P |
Pharmaceutical compositions
|
US5912014A
(en)
*
|
1996-03-15 |
1999-06-15 |
Unigene Laboratories, Inc. |
Oral salmon calcitonin pharmaceutical products
|
SE9601421D0
(en)
*
|
1996-04-12 |
1996-04-12 |
Astra Ab |
New composition
|
DK0906089T3
(en)
|
1996-05-13 |
2003-12-08 |
Novartis Consumer Health Sa |
The buccal delivery system
|
US5726154A
(en)
*
|
1996-06-28 |
1998-03-10 |
University Of Utah Research Foundation |
Stabilization and oral delivery of calcitonin
|
CA2259418A1
(en)
*
|
1996-07-11 |
1998-01-22 |
Farmarc Nederland B.V. |
Pharmaceutical composition containing acid addition salt of basic drug
|
DE19646392A1
(en)
*
|
1996-11-11 |
1998-05-14 |
Lohmann Therapie Syst Lts |
Preparation for use in the oral cavity with a layer containing pressure-sensitive adhesive, pharmaceuticals or cosmetics for dosed delivery
|
US20040023948A1
(en)
*
|
1997-03-24 |
2004-02-05 |
Green Richard David |
Fast-dispersing dosage form containing 5-HT1 agonists
|
GB9706089D0
(en)
*
|
1997-03-24 |
1997-05-14 |
Scherer Ltd R P |
Pharmaceutical composition
|
TW586934B
(en)
*
|
1997-05-19 |
2004-05-11 |
Sumitomo Pharma |
Immunopotentiating composition
|
US6197331B1
(en)
|
1997-07-24 |
2001-03-06 |
Perio Products Ltd. |
Pharmaceutical oral patch for controlled release of pharmaceutical agents in the oral cavity
|
US6177282B1
(en)
*
|
1997-08-12 |
2001-01-23 |
Mcintyre John A. |
Antigens embedded in thermoplastic
|
GB9717770D0
(en)
*
|
1997-08-21 |
1997-10-29 |
Scherer Ltd R P |
Pharmaceutical composition
|
US8765177B2
(en)
*
|
1997-09-12 |
2014-07-01 |
Columbia Laboratories, Inc. |
Bioadhesive progressive hydration tablets
|
US7153845B2
(en)
*
|
1998-08-25 |
2006-12-26 |
Columbia Laboratories, Inc. |
Bioadhesive progressive hydration tablets
|
US6074674A
(en)
*
|
1997-10-31 |
2000-06-13 |
University Of Kentucky Research Foundation |
Formulations for sustained-release of topical anesthetics and methods of making and using same
|
US7070799B1
(en)
*
|
1998-02-10 |
2006-07-04 |
Generex Pharmaceuticals, Inc. |
Method for administering insulin to the buccal region
|
US6221378B1
(en)
|
1998-02-10 |
2001-04-24 |
Generex Pharmaceuticals Incorporated |
Mixed micellar delivery system and method of preparation
|
US5990134A
(en)
*
|
1998-08-12 |
1999-11-23 |
Taylor Pharmaceuticals |
Oral droperidol compositions and method for treating migraine
|
US5981552A
(en)
*
|
1998-10-23 |
1999-11-09 |
Taylor Pharmaceuticals |
Sublingual and buccal compositions of droperidol and method for treating migraine
|
US5997884A
(en)
*
|
1998-02-12 |
1999-12-07 |
Taylor Pharmaceuticals |
Compositions and method for treating migraine
|
US20030091629A1
(en)
*
|
1998-03-27 |
2003-05-15 |
Cima Labs Inc. |
Sublingual buccal effervescent
|
US6974590B2
(en)
*
|
1998-03-27 |
2005-12-13 |
Cima Labs Inc. |
Sublingual buccal effervescent
|
US6103257A
(en)
*
|
1998-07-17 |
2000-08-15 |
Num-Pop, Inc. |
System for delivering pharmaceuticals to the buccal mucosa
|
US6368625B1
(en)
|
1998-08-12 |
2002-04-09 |
Cima Labs Inc. |
Orally disintegrable tablet forming a viscous slurry
|
ATE252889T1
(en)
*
|
1998-08-19 |
2003-11-15 |
Skyepharma Canada Inc |
INJECTABLE AQUEOUS PROPOFOL DISPERSIONS
|
US6358060B2
(en)
|
1998-09-03 |
2002-03-19 |
Jsr Llc |
Two-stage transmucosal medicine delivery system for symptom relief
|
US6344222B1
(en)
|
1998-09-03 |
2002-02-05 |
Jsr Llc |
Medicated chewing gum delivery system for nicotine
|
SE9803239D0
(en)
*
|
1998-09-24 |
1998-09-24 |
Diabact Ab |
Composition for the treatment of acute pain
|
SE9803240D0
(en)
*
|
1998-09-24 |
1998-09-24 |
Diabact Ab |
A pharmaceutical composition having a rapid action
|
US6294153B1
(en)
|
1998-12-21 |
2001-09-25 |
Generex Pharmaceuticals, Inc. |
Aerosol pharmaceutical formulation for pulmonary and nasal delivery
|
US6884792B2
(en)
*
|
1999-01-08 |
2005-04-26 |
Marvin B. Bacaner |
Bretylium compositions and kits and their use in preventing and treating cardiovascular conditions
|
US6242473B1
(en)
*
|
1999-01-08 |
2001-06-05 |
Maxim Pharmaceuticals, Inc. |
Treatment and prevention of reactive oxygen metabolite-mediated cellular damage
|
US6270781B1
(en)
|
1999-01-08 |
2001-08-07 |
Maxim Pharmaceuticals, Inc. |
Method and compositions for topical treatment of damaged tissue using reactive oxygen metabolite production or release inhibitors
|
WO2000040232A2
(en)
|
1999-01-08 |
2000-07-13 |
Bacaner Marvin B |
Bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions
|
US6552024B1
(en)
|
1999-01-21 |
2003-04-22 |
Lavipharm Laboratories Inc. |
Compositions and methods for mucosal delivery
|
US7658938B2
(en)
|
1999-02-22 |
2010-02-09 |
Merrion Reasearch III Limited |
Solid oral dosage form containing an enhancer
|
US20070148228A1
(en)
*
|
1999-02-22 |
2007-06-28 |
Merrion Research I Limited |
Solid oral dosage form containing an enhancer
|
US8119159B2
(en)
*
|
1999-02-22 |
2012-02-21 |
Merrion Research Iii Limited |
Solid oral dosage form containing an enhancer
|
US6350432B1
(en)
|
1999-03-19 |
2002-02-26 |
Generex Pharmaceuticals Incorporated |
Pressurized container having an aerosolized pharmaceutical composition
|
US6248760B1
(en)
*
|
1999-04-14 |
2001-06-19 |
Paul C Wilhelmsen |
Tablet giving rapid release of nicotine for transmucosal administration
|
AU5871000A
(en)
*
|
1999-06-11 |
2001-01-02 |
Paul G. Abrams |
High dose radionuclide complexes for bone marrow suppression
|
DE19932603A1
(en)
|
1999-07-13 |
2001-01-25 |
Gruenenthal Gmbh |
Multi-layer film containing active substance made of in-situ cross-linked hydrophilic polymers
|
AU6528400A
(en)
|
1999-08-23 |
2001-03-19 |
David M. Ockert |
Triple drug therapy for the treatment of narcotic and alcohol withdrawal symptoms
|
EP1255565A1
(en)
*
|
2000-01-13 |
2002-11-13 |
MERCK PATENT GmbH |
Pharmaceutical preparations containing 2-pyrrolidone as the dissolving intermediary
|
AU2001261744A1
(en)
*
|
2000-05-19 |
2001-12-03 |
Npd Llc |
Chewing gums, lozenges, candies, tablets, liquids, and sprays for efficient delivery of medications and dietary supplements
|
US6526993B1
(en)
*
|
2000-09-12 |
2003-03-04 |
Eugene C. Wagner |
Dental implement with comfit grip
|
US6365215B1
(en)
*
|
2000-11-09 |
2002-04-02 |
International Flavors & Fragrances Inc. |
Oral sensory perception-affecting compositions containing dimethyl sulfoxide, complexes thereof and salts thereof
|
US20020106407A1
(en)
*
|
2000-12-11 |
2002-08-08 |
Dennis Coleman |
Method and apparatus for treating breakthrough pain
|
US20020160043A1
(en)
*
|
2001-02-27 |
2002-10-31 |
Dennis Coleman |
Compositions and method of manufacture for oral dissolvable dosage forms
|
US20030118628A1
(en)
*
|
2001-04-05 |
2003-06-26 |
Tutuncu Nurhan Pinar |
Confectionery product having a salivation region and an oral comfort region
|
EP1390383B1
(en)
|
2001-05-11 |
2012-02-29 |
Isis Pharmaceuticals, Inc. |
Antisense permeation enhancers
|
HUP0401022A3
(en)
*
|
2001-08-14 |
2006-11-28 |
Biotie Therapies Corp |
Method for the preparation of pharmaceutical compositions containing opioid antagonist for treating alcoholism or alcohol abuse
|
DE10141650C1
(en)
|
2001-08-24 |
2002-11-28 |
Lohmann Therapie Syst Lts |
Safe transdermal therapeutic system for administration of fentanyl or analogous analgesics, having matrix layer of carboxy group-free polyacrylate adhesive providing high permeation rate
|
US20030049304A1
(en)
*
|
2001-08-29 |
2003-03-13 |
Somani Jitendra Krishan |
Quiescently frozen ice products
|
IL160928A0
(en)
*
|
2001-10-19 |
2004-08-31 |
Maxim Pharm Inc |
Use of histamine to treat liver disease
|
EP1448127A1
(en)
*
|
2001-11-06 |
2004-08-25 |
Maxim Pharmaceuticals, Inc. |
Compositions for the treatment of infectious diseases
|
GB0210397D0
(en)
*
|
2002-05-07 |
2002-06-12 |
Ferring Bv |
Pharmaceutical formulations
|
EP1534302A4
(en)
*
|
2002-08-22 |
2009-01-07 |
Nutrition 21 Inc |
Arginine silicate inositol complex and use thereof
|
US6592908B1
(en)
|
2002-09-23 |
2003-07-15 |
Albert Crum |
Nutritional or therapeutic compositions
|
US20040115244A1
(en)
*
|
2002-12-17 |
2004-06-17 |
Holgate Eric Jamison |
Methods and compositions for nicotine replacement therapy
|
US8088734B2
(en)
*
|
2003-01-21 |
2012-01-03 |
Unigene Laboratories Inc. |
Oral delivery of peptides
|
US20080213363A1
(en)
*
|
2003-01-23 |
2008-09-04 |
Singh Nikhilesh N |
Methods and compositions for delivering 5-HT3 antagonists across the oral mucosa
|
US20040253307A1
(en)
*
|
2003-02-04 |
2004-12-16 |
Brian Hague |
Sugar-free oral transmucosal solid dosage forms and uses thereof
|
US20060062812A1
(en)
*
|
2003-03-11 |
2006-03-23 |
Calvin Ross |
Novel compositions
|
US6966252B2
(en)
|
2003-03-31 |
2005-11-22 |
Mcneil-Ppc, Inc. |
Hydrophilic substance dispensing device
|
US20040202717A1
(en)
|
2003-04-08 |
2004-10-14 |
Mehta Atul M. |
Abuse-resistant oral dosage forms and method of use thereof
|
BRPI0302736B8
(en)
|
2003-06-02 |
2021-05-25 |
Ems S/A |
pharmaceutical composition based on ketorolac or one of its pharmaceutically acceptable salts for sublingual use
|
WO2005004989A2
(en)
*
|
2003-07-01 |
2005-01-20 |
Todd Maibach |
Film comprising therapeutic agents
|
WO2005018565A2
(en)
*
|
2003-08-21 |
2005-03-03 |
Transoral Pharmaceuticals, Inc. |
Compositions for delivering 5-ht agonists across the oral mucosa and methods of use thereof
|
US20050042281A1
(en)
*
|
2003-08-21 |
2005-02-24 |
Singh Nikhilesh N. |
Compositions for delivering therapeutic agents across the oral mucosa
|
US7282217B1
(en)
|
2003-08-29 |
2007-10-16 |
Kv Pharmaceutical Company |
Rapidly disintegrable tablets
|
US8627828B2
(en)
*
|
2003-11-07 |
2014-01-14 |
U.S. Smokeless Tobacco Company Llc |
Tobacco compositions
|
US8469036B2
(en)
|
2003-11-07 |
2013-06-25 |
U.S. Smokeless Tobacco Company Llc |
Tobacco compositions
|
US20050171192A1
(en)
*
|
2003-12-11 |
2005-08-04 |
Gehlsen Kurt R. |
Use of histamine to treat bone disease
|
CA2549642C
(en)
*
|
2003-12-31 |
2012-10-30 |
Cima Labs Inc. |
Effervescent oral opiate dosage forms and methods of administering opiates
|
WO2005065317A2
(en)
*
|
2003-12-31 |
2005-07-21 |
Cima Labs Inc. |
Effervescent oral fentanyl dosage form
|
EA010826B1
(en)
*
|
2003-12-31 |
2008-12-30 |
Сайма Лэбс Инк. |
Fentanyl dosage form for oral administration, methods of making thereof and methods of treatment
|
KR20150038745A
(en)
*
|
2004-02-17 |
2015-04-08 |
트랜스셉트 파마슈티칼스, 인코포레이티드 |
Compositions for delivering hypnotic agents across the oral mucosa and methods of use thereof
|
WO2006009975A2
(en)
*
|
2004-06-22 |
2006-01-26 |
Maxim Pharmaceuticals, Inc. |
Histamine to treat disorders affecting muscle function
|
US20060004035A1
(en)
*
|
2004-06-25 |
2006-01-05 |
Cephalon, Inc. |
System for identification of a pharmaceutical product
|
US20060029665A1
(en)
*
|
2004-08-03 |
2006-02-09 |
Transoral Pharmaceuticals, Inc. |
Pilocarpine compositions and methods of use thereof
|
WO2006073514A2
(en)
*
|
2004-08-25 |
2006-07-13 |
Tufts University |
Compositions, methods and kits for repressing virulence in gram positive bacteria
|
US20060051413A1
(en)
*
|
2004-09-08 |
2006-03-09 |
Chow Sing S M |
Method of enhancing absorptions of transmucosal administration formulations
|
US20050196517A1
(en)
*
|
2005-02-14 |
2005-09-08 |
Mars, Incorporated |
Edible product having discrete regions with different heats of solution
|
US20070225322A1
(en)
*
|
2005-05-25 |
2007-09-27 |
Transoral Pharmaceuticals, Inc. |
Compositions and methods for treating middle-of-the night insomnia
|
US8242131B2
(en)
*
|
2005-05-25 |
2012-08-14 |
Transcept Pharmaceuticals, Inc. |
Methods of treating middle-of-the-night insomnia
|
US20070287740A1
(en)
*
|
2005-05-25 |
2007-12-13 |
Transcept Pharmaceuticals, Inc. |
Compositions and methods of treating middle-of-the night insomnia
|
US20070104763A1
(en)
*
|
2005-11-10 |
2007-05-10 |
Navinta Llc |
Composition of fentanyl citrate oral solid transmucosal dosage form, excipient and binding material therefore, and methods of making
|
US8679545B2
(en)
*
|
2005-11-12 |
2014-03-25 |
The Regents Of The University Of California |
Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract
|
US8497258B2
(en)
|
2005-11-12 |
2013-07-30 |
The Regents Of The University Of California |
Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
|
US8324192B2
(en)
|
2005-11-12 |
2012-12-04 |
The Regents Of The University Of California |
Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
|
US8202535B2
(en)
*
|
2006-01-06 |
2012-06-19 |
Acelrx Pharmaceuticals, Inc. |
Small-volume oral transmucosal dosage forms
|
US8357114B2
(en)
|
2006-01-06 |
2013-01-22 |
Acelrx Pharmaceuticals, Inc. |
Drug dispensing device with flexible push rod
|
US8535714B2
(en)
|
2006-01-06 |
2013-09-17 |
Acelrx Pharmaceuticals, Inc. |
Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
|
US8252328B2
(en)
*
|
2006-01-06 |
2012-08-28 |
Acelrx Pharmaceuticals, Inc. |
Bioadhesive drug formulations for oral transmucosal delivery
|
US8865743B2
(en)
|
2006-01-06 |
2014-10-21 |
Acelrx Pharmaceuticals, Inc. |
Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
|
US9289583B2
(en)
*
|
2006-01-06 |
2016-03-22 |
Acelrx Pharmaceuticals, Inc. |
Methods for administering small volume oral transmucosal dosage forms using a dispensing device
|
US8252329B2
(en)
|
2007-01-05 |
2012-08-28 |
Acelrx Pharmaceuticals, Inc. |
Bioadhesive drug formulations for oral transmucosal delivery
|
US9066847B2
(en)
*
|
2007-01-05 |
2015-06-30 |
Aceirx Pharmaceuticals, Inc. |
Storage and dispensing devices for administration of oral transmucosal dosage forms
|
US8753308B2
(en)
|
2006-01-06 |
2014-06-17 |
Acelrx Pharmaceuticals, Inc. |
Methods for administering small volume oral transmucosal dosage forms using a dispensing device
|
CN101437522A
(en)
*
|
2006-04-07 |
2009-05-20 |
默里昂研究Ⅲ有限公司 |
Solid oral dosage form containing an enhancer
|
US20070260491A1
(en)
*
|
2006-05-08 |
2007-11-08 |
Pamela Palmer |
System for delivery and monitoring of administration of controlled substances
|
WO2007143674A2
(en)
*
|
2006-06-05 |
2007-12-13 |
Verus Pharmaceuticals, Inc. |
Methods for buccal, lingual or sublingual dosing regimens of epinephrine for the treatment of allergic emergencies
|
WO2007146234A2
(en)
*
|
2006-06-09 |
2007-12-21 |
Merrion Research Ii Limited |
Solid oral dosage form containing an enhancer
|
US20070299687A1
(en)
*
|
2006-06-23 |
2007-12-27 |
Pamela Palmer |
Inpatient system for patient-controlled delivery of oral transmucosal medications dosed as needed
|
BRPI0714712B8
(en)
|
2006-07-21 |
2021-05-25 |
Biodelivery Sciences Int Inc |
drug delivery device
|
US8642016B2
(en)
*
|
2006-07-21 |
2014-02-04 |
Jsrnti, Llc |
Medicinal delivery system, and related methods
|
US8158609B1
(en)
|
2006-11-02 |
2012-04-17 |
Novartis Ag |
Use of cyclodextrins as an active ingredient for treating dry AMD and solubilizing drusen
|
US20090214442A1
(en)
*
|
2006-12-01 |
2009-08-27 |
Cephalon, Inc. |
Oral Transmucosal Nicotine Dosage Form
|
JP2010511611A
(en)
*
|
2006-12-01 |
2010-04-15 |
シマ ラブス インク. |
Oral transmucosal nicotine dosage form
|
EP1938756A1
(en)
*
|
2006-12-29 |
2008-07-02 |
Qiagen GmbH |
Method and materials for triggered release of a biological sample
|
EP2112923A1
(en)
|
2007-01-22 |
2009-11-04 |
Targacept Inc. |
Intranasal, buccal, and sublingual administration of metanicotine analogs
|
AU2008216867B2
(en)
|
2007-02-09 |
2014-01-30 |
Durect Corporation |
Transoral dosage forms comprising sufentanil and naloxone
|
US20100215774A1
(en)
*
|
2007-02-09 |
2010-08-26 |
Todd Maibach |
Film comprising nitroglycerin
|
MX2009013384A
(en)
*
|
2007-06-08 |
2010-01-25 |
Addrenex Pharmaceuticals Inc |
Extended release formulation and method of treating adrenergic dysregulation.
|
US20100172991A1
(en)
*
|
2007-06-08 |
2010-07-08 |
Henry Joseph Horacek |
Extended Release Formulation and Methods of Treating Adrenergic Dysregulation
|
US20090004254A1
(en)
*
|
2007-06-19 |
2009-01-01 |
Todd Maibach |
Film comprising active drugs
|
EP2025332A1
(en)
*
|
2007-08-13 |
2009-02-18 |
Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) |
Clay-based aromatised therapeutic composition
|
US20090143343A1
(en)
*
|
2007-11-13 |
2009-06-04 |
Meritage Pharma, Inc. |
Compositions for the treatment of inflammation of the gastrointestinal tract
|
US20100216754A1
(en)
*
|
2007-11-13 |
2010-08-26 |
Meritage Pharma, Inc. |
Compositions for the treatment of inflammation of the gastrointestinal tract
|
DK2214679T3
(en)
|
2007-11-13 |
2019-05-20 |
Meritage Pharma Inc |
CORTICOSTEROID COMPOSITIONS
|
US20090123551A1
(en)
*
|
2007-11-13 |
2009-05-14 |
Meritage Pharma, Inc. |
Gastrointestinal delivery systems
|
US20090264392A1
(en)
*
|
2008-04-21 |
2009-10-22 |
Meritage Pharma, Inc. |
Treating eosinophilic esophagitis
|
BRPI0912384A2
(en)
*
|
2008-05-07 |
2015-10-13 |
Merrion Res Iii Ltd |
composition and method for preparing a composition
|
CA2726259C
(en)
|
2008-06-04 |
2014-07-29 |
Colgate-Palmolive Company |
Oral care implement with cavitation system
|
US20100055050A1
(en)
*
|
2008-08-30 |
2010-03-04 |
Kathleen Moore |
Nicotine chewing gum on a stick
|
US8945592B2
(en)
|
2008-11-21 |
2015-02-03 |
Acelrx Pharmaceuticals, Inc. |
Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same
|
US20100190739A1
(en)
*
|
2008-12-15 |
2010-07-29 |
Fleming And Company, Pharmaceuticals |
Rapidly Dissolving Vitamin Formulation and Methods of Using the Same
|
US20100215743A1
(en)
*
|
2009-02-25 |
2010-08-26 |
Leonard Thomas W |
Composition and drug delivery of bisphosphonates
|
US20110097401A1
(en)
*
|
2009-06-12 |
2011-04-28 |
Meritage Pharma, Inc. |
Methods for treating gastrointestinal disorders
|
CN108295241A
(en)
|
2009-06-18 |
2018-07-20 |
宁静制药公司 |
The desmopressin administration of safety
|
US8475832B2
(en)
*
|
2009-08-07 |
2013-07-02 |
Rb Pharmaceuticals Limited |
Sublingual and buccal film compositions
|
AU2010314994B2
(en)
|
2009-11-09 |
2016-10-06 |
Spotlight Technology Partners Llc |
Fragmented hydrogels
|
WO2011057131A1
(en)
|
2009-11-09 |
2011-05-12 |
Spotlight Technology Partners Llc |
Polysaccharide based hydrogels
|
US20110182985A1
(en)
*
|
2010-01-28 |
2011-07-28 |
Coughlan David C |
Solid Pharmaceutical Composition with Enhancers and Methods of Preparing thereof
|
WO2011120033A1
(en)
*
|
2010-03-26 |
2011-09-29 |
Merrion Research Iii Limited |
Pharmaceutical compositions of selective factor xa inhibitors for oral administration
|
US8623409B1
(en)
|
2010-10-20 |
2014-01-07 |
Tris Pharma Inc. |
Clonidine formulation
|
KR20140026354A
(en)
|
2011-01-07 |
2014-03-05 |
메리온 리서치 Ⅲ 리미티드 |
Pharmaceutical compositions of iron for oral administration
|
BR112014003651B1
(en)
|
2011-08-18 |
2022-03-29 |
Biodelivery Sciences International, Inc |
Misuse-resistant mucoadhesive devices for the release of buprenorphine
|
SI2915525T1
(en)
|
2011-09-19 |
2022-01-31 |
Orexo Ab |
Sublingual abuse-resistant tablets comprising buprenorphine and naloxone
|
US9901539B2
(en)
|
2011-12-21 |
2018-02-27 |
Biodelivery Sciences International, Inc. |
Transmucosal drug delivery devices for use in chronic pain relief
|
CA2860231A1
(en)
|
2011-12-28 |
2013-07-04 |
Pozen Inc. |
Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid
|
NZ701428A
(en)
|
2012-05-02 |
2016-10-28 |
Orexo Ab |
New alfentanil composition for the treatment of acute pain
|
US20160051496A1
(en)
*
|
2014-08-20 |
2016-02-25 |
Tsu-I Catherine Wang |
Oral Transmucosal Compositions Including C-SERMs for Treating Female Infertility
|
US20160051495A1
(en)
*
|
2014-08-20 |
2016-02-25 |
Professional Compounding Centers Of America |
Oral Transmucosal Compositions including C-SERMs for Low Testosterone Levels in Men
|
EP3193824B1
(en)
|
2014-08-29 |
2023-07-05 |
The ProImmune Company, LLC |
A composition for use in treating hyperlipidemia, hypercholesterolemia and/or hypertriglyceridemia via physiologically synthesised glutathione
|
WO2016120378A1
(en)
|
2015-01-29 |
2016-08-04 |
Novo Nordisk A/S |
Tablets comprising glp-1 agonist and enteric coating
|
US9744239B2
(en)
|
2015-01-30 |
2017-08-29 |
Par Pharmaceutical, Inc. |
Vasopressin formulations for use in treatment of hypotension
|
US9744209B2
(en)
|
2015-01-30 |
2017-08-29 |
Par Pharmaceutical, Inc. |
Vasopressin formulations for use in treatment of hypotension
|
US9687526B2
(en)
|
2015-01-30 |
2017-06-27 |
Par Pharmaceutical, Inc. |
Vasopressin formulations for use in treatment of hypotension
|
US9937223B2
(en)
|
2015-01-30 |
2018-04-10 |
Par Pharmaceutical, Inc. |
Vasopressin formulations for use in treatment of hypotension
|
US9925233B2
(en)
|
2015-01-30 |
2018-03-27 |
Par Pharmaceutical, Inc. |
Vasopressin formulations for use in treatment of hypotension
|
US9750785B2
(en)
|
2015-01-30 |
2017-09-05 |
Par Pharmaceutical, Inc. |
Vasopressin formulations for use in treatment of hypotension
|
US11191735B2
(en)
|
2015-03-13 |
2021-12-07 |
Nutrition 21, Llc |
Arginine silicate for periodontal disease
|
US20170135969A1
(en)
|
2015-11-12 |
2017-05-18 |
Jds Therapeutics, Llc |
Topical arginine-silicate-inositol for wound healing
|
MX2019002468A
(en)
|
2016-09-01 |
2019-09-18 |
Jds Therapeutics Llc |
Magnesium biotinate compositions and methods of use.
|
GB201709141D0
(en)
|
2017-06-08 |
2017-07-26 |
Klaria Pharma Holding Ab |
Pharmaceutical formulation
|
WO2020092431A1
(en)
|
2018-11-02 |
2020-05-07 |
Nutrition 21, Llc |
Compositions containing inositol-stabilized arginine silicate complexes and inositol for improving cognitive function in video gamers
|
GB2613672A
(en)
|
2019-12-16 |
2023-06-14 |
Nutrition 21 Llc |
Methods of production of aginine-silicate complexes
|
US11918689B1
(en)
|
2020-07-28 |
2024-03-05 |
Tris Pharma Inc |
Liquid clonidine extended release composition
|